Pneumocystis jirovecii Pneumonia in Patients with Nephrotic Syndrome: Application of Lymphocyte Subset Analysis in Predicting Clinical Outcomes

Figure 1

Predictors for PCP mortality and the influence on clinical course; (a–c) CD4⁺ T lymphocyte counts, T lymphocyte counts, and CD4/CD8 ratios in survivors and nonsurvivors. Error bars, mean ± SEM. (d) Mortality in patients with CD4⁺ T lymphocyte counts <71/μl and ≥71/μl. The dashed line indicates overall mortality of all patients (33.3%). (e) Proportion of mechanical ventilation in patients with CD4⁺ T lymphocyte counts <71/μl and ≥71/μl. Percentages (85.7% vs. 33.3%) shown in the graph represent the proportions of mechanical ventilation including both noninvasive and invasive ventilation. (f) Survival analysis of in-ICU patients stratified for CD4⁺ T lymphocyte counts <71/μl and ≥71/μl. value, log-rank test. Non-MV: mechanical ventilation not applied, NIMV: noninvasive mechanical ventilation, and IMV: invasive mechanical ventilation.

(a)

(b)

(c)

(d)

(e)

(f)